SNP Array Analysis of Borderline Melanocytic Tumors
Offered By: Cancer Genomics Consortium via YouTube
Course Description
Overview
Explore the application of SNP array analysis in diagnosing borderline melanocytic tumors through this informative 24-minute conference talk presented at the 2022 Cancer Genomics Consortium Annual Meeting. Dive into the complexities of clinical cancer genomics as Dr. Katherine Geiersbach discusses the latest advancements in SNP array technology for accurately identifying genomic alterations in challenging melanocytic lesions. Gain insights into best practices for clinical cancer genomic testing and learn how this cutting-edge approach can improve diagnostic accuracy and guide appropriate treatment decisions for patients with ambiguous melanocytic tumors. Discover the role of the Cancer Genomics Consortium in promoting education and advancing the field of clinical cancer genomics to ensure more precise diagnoses and personalized therapies for cancer patients.
Syllabus
SNP Array Analysis of Borderline Melanocytic Tumors
Taught by
Cancer Genomics Consortium
Related Courses
Fostering Change: ACMG's New Diversity, Equity and Inclusion CommitteeAmbry Genetics via YouTube Somatic Mutations and Their Contribution to Bone Marrow Failure and Inflammation
Cancer Genomics Consortium via YouTube TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Cancer Genomics Consortium via YouTube Incorporating Genomic Information in the Treatment of MDS
Cancer Genomics Consortium via YouTube ISCN 2024 Update: Preview of New Genomic Mapping Nomenclature
Cancer Genomics Consortium via YouTube